Friday, November 20, 2015
Print Current Day:
|
|
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
NEW TECHNIQUES, TECHNOLOGIES, CONCEPTS – CAROTID RELATED
Moderators:Claudio J. Schonholz, MD / Sriram S. Iyer, MD, FACC
|
|
x | |
6:39 AM - 6:45 AM | Atherosclerotic Plaque Regression: Is It Now A Reality: How Can It Occur: And What Are The Expectations For The Future |
Presenter(s):Kosmas I. Paraskevas, MD | |
6:46 AM - 6:51 AM | Current Optimal Methods To Evaluate Plaque Instability With Asymptomatic Carotid Stenosis (ACS) |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Slides in PDF | |
6:52 AM - 6:57 AM | Juxtaluminal Black Area (JBA) On Duplex Determines Stroke Risk In ACS Patients: How To Determine And Quantitate It: Can It Be Changed: What Other Factors Quantitate Risk |
Presenter(s):Andrew N. Nicolaides, MS, FRCS / Stavros Kakkos, MD, PhD | |
View Slides in PDF | |
6:58 AM - 7:03 AM | DEBATE: Patch Closure After CEA Should Be Used Most Of The Time: The Level 1 Evidence Shows It |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
7:04 AM - 7:09 AM | DEBATE: Patch Closure After CEA Is Usually Not Needed Despite The Level 1 Evidence |
Presenter(s):Nicholas J. Gargiulo III, MD, FACS, RPVI, RVT, RDMS | |
View Slides in PDF | |
7:10 AM - 7:15 AM | DEBATE: If Certain Techniques Are Employed, Patch Closure After CEA Is Not Always Needed And Patch Closures Have Complications: What Are They |
Presenter(s):Glenn M. LaMuraglia, MD | |
View Slides in PDF | |
7:16 AM - 7:21 AM | Is Preop Coronary Angiography Before CEA Beneficial Over The Long-Term: Based On A RCT |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Slides in PDF | |
MESH COVERED CAROTID STENTS | |
7:22 AM - 7:27 AM | Midterm Results With A Micromesh Covered Stent For CAS (The Roadsaver Stent From Terumo); What Are The Differences Between The 3 Available Mesh Covered Stents |
Presenter(s):Max Amor, MD | |
View Slides in PDF | |
7:28 AM - 7:33 AM | Technical Aspects And Results With The Gore Scaffold Mesh Covered Stent For CAS: Are Any Of These Mesh Covered Stents Ready For Prime Time |
Presenter(s):Peter A. Schneider, MD / Claudio J. Schonholz, MD | |
View Slides in PDF | |
7:34 AM - 7:39 AM | MicroNet Covered Embolic Prevention Carotid Stent System: From CARENET And PARADIGM Studies To Routine Clinical Practice |
Presenter(s):Piotr Musialek, MD, DPhil | |
View Slides in PDF | |
7:40 AM - 7:45 AM | Update On Value Of Contrast Enhanced 3D Duplex And Carotid Artery Flow Dynamics To Detect Plaque Changes And Identify High Risk ACS Patients For Invasive Treatment |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
7:46 AM - 7:51 AM | MRI Can Determine Carotid Plaque Characteristics And Embolic Risk Prospectively: These MRI Findings Correlate With Symptoms, TCD Hits And Cognitive Changes |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
7:52 AM - 8:00 AM | Panel Discussion |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
MORE ABOUT COMPLEX ANEURYSM TREATMENT AND SPINAL CORD ISCHEMIA (SCI)
Moderators:Gustavo S. Oderich, MD, FACS / Christian D. Etz, MD, PhD
|
|
x | |
SPINAL CORD ISCHEMIA (SCI) AND ITS PREVENTION | |
8:00 AM - 8:05 AM | Mechanisms Of Neuronal Death In SCI With Aortic Repairs And What Can Be Done To Minimize It: CSF Drainage And High BP Will Not Stop All SCI: An Anesthesiologist’s Perspective |
Presenter(s):Hamdy Awad, MD | |
View Slides in PDF | |
8:06 AM - 8:11 AM | Pitfalls And Safeguards In Spinal Cord Protection During And After TEVAR |
Presenter(s):Vicente Riambau, MD, PhD | |
View Slides in PDF | |
8:12 AM - 8:17 AM | Institutional And Administrative Barriers To Adequate Spinal Cord Protection Treatment After TAAA Repair – Open And Endo |
Presenter(s):Charles W. Acher, MD | |
View Slides in PDF | |
8:18 AM - 8:23 AM | New Concepts In Causes And Treatment Of SCI With TAAA Repairs – Open And Endo: Why Preemptive Ischemic Preconditioning With Coil Embolization Of Intercostals May Help Prevent SCI |
Presenter(s):Christian D. Etz, MD, PhD | |
View Slides in PDF | |
8:24 AM - 8:29 AM | Optimal Approaches To Decrease SCI After TEVAR And Open TAAA Repair |
Presenter(s):Michael J. Jacobs, MD | |
View Slides in PDF | |
8:30 AM - 8:35 AM | 2 Staging B/FEVAR Procedures For Complex TAAAs Is A Better Way Than Leaving A Patent Branch To Prevent SCI: Why |
Presenter(s):Matthew J. Eagleton, MD | |
View Slides in PDF | |
8:36 AM - 8:41 AM | Selective Staging Based On Spinal Cord Function Monitoring Is The Best Way To Prevent SCI With TAAA F/BEVAR Repairs: Intrasac Pressure Measurements And Leaving A Patent Branch May Be Appropriate For Some Cases |
Presenter(s):Geert Willem H. Schurink, MD, PhD | |
View Slides in PDF | |
8:42 AM - 8:47 AM | Impact Of Early Pelvic And Lower Extremity Reperfusion In Preventing SCI During TAAA Endovascular Repairs: Techniques To Achieve It |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
8:48 AM - 8:53 AM | Predictors Of SCI During TEVAR For TBAD And Strategies To Prevent It |
Presenter(s):Xin Li, MD / Chang Shu, MD | |
View Slides in PDF | |
8:54 AM - 8:59 AM | Paraplegia After TEVAR: Etiology And Strategies To Prevent It |
Presenter(s):Germano Melissano, MD / Yamume Tshomba, MD / Roberto Chiesa, MD | |
View Slides in PDF | |
9:00 AM - 9:07 AM | Panel Discussion |
9:07 AM - 9:23 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
x | |
9:23 AM - 9:28 AM | Safety And Effectiveness Of CAS With Radiation Induced Carotid Stenosis: Review Of A Multicenter Experience |
Presenter(s):Peter L. Faries, MD, FACS | |
View Slides in PDF | |
9:29 AM - 9:34 AM | Pathogenesis Of Carotid Radiation Arteritis: What Is Its Impact On How It Should Be Treated |
Presenter(s):Beatrice R. Amann-Vesti, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Carotid Artery Aneurysms: Is Open Surgery The Best Treatment For Most: When Are Endovascular Techniques Indicated |
Presenter(s):Gregg S. Landis, MD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | How To Increase Intelligence By Increasing Cerebral Blood Flow: Can A Pill Do It |
Presenter(s):Juan C. Parodi, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | Asymptomatic Carotid Stenosis (ACS) Is Associated With Cognitive Impairment: Does Correction Of The Stenosis With CEA Or CAS Reverse The Cognitive Defect |
Presenter(s):Brajesh K. Lal, MD | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Implications Of The 2014 Revisions Of The AHA Carotid Guidelines For Symptomatic Patients: What Was Changed And What Should Have Been Changed |
Presenter(s):Kosmas I. Paraskevas, MD | |
View Slides in PDF | |
9:59 AM - 10:05 AM | Panel Discussion |
PROGRESS IN EMBOLIC BRAIN PROTECTION DURING CAS | |
Moderator(s): Peter L. Faries, MD, FACS / Juan C. Parodi, MD | |
10:05 AM - 10:10 AM | What Is New In Cerebral Embolic Protection Devices |
Presenter(s):Mark H. Wholey, MD | |
View Slides in PDF | |
10:11 AM - 10:16 AM | Some Form Of Proximal Brain Protection Should Be The Method Of Choice With CAS And Why |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD / Horst Sievert, MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM | CAS In High Risk Patients Has A Lower Embolic Stroke Risk With The Silk Road Cervical Access And Reversal Of Flow System: Outcomes Can Be As Good As With CEA (From The PROOF Trial) |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Slides in PDF | |
10:23 AM - 10:28 AM | Transcervical Carotid Open Exposure And CAS With The Silk Road System And Flow Reversal: Favorable Results Of The ROADSTER Trial In High Risk Patients |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
View Slides in PDF | |
10:29 AM - 10:34 AM | DEBATE: A Surgeon’s View Of The Silk Road System Of Cervical Access And Reversal Of Flow For CAS |
Presenter(s):L. Nelson Hopkins, MD | |
View Slides in PDF | |
10:35 AM - 10:40 AM | DEBATE: An Interventionalist’s View Of The Silk Road System Of Cervical Access And Reversal Of Flow For CAS |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
10:41 AM - 10:47 AM | Panel Discussiion |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
MORE CAROTID RELATED TOPICS: CAS Vs. CEA
Moderators:L. Nelson Hopkins, MD / Frank J. Veith, MD
|
|
x | |
10:47 AM - 10:52 AM | Double Filtration Embolic Brain Protection During CAS Improves Outcomes: A Novel PTA Balloon With An Integrated Filter Helps To Do This: The Paladin Balloon |
Presenter(s):Ravish Sachar, MD | |
10:53 AM - 10:58 AM | Effect Of Statins On Restenosis And Late Patient Survival After CEA |
Presenter(s):Ali F. AbuRahma, MD | |
View Slides in PDF | |
10:59 AM - 11:04 AM | How Enlightened Surgeons Should Select Asymptomatic Carotid Stenosis (ACS) Patients For CEA; For CAS; For BMRx Alone: All ACS Patients Should Get BMRx |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Striking Variability In Preop Carotid Imaging Before Invasive Treatment In Different Locations And Why It’s Bad For Patient Care |
Presenter(s):Andres Schanzer, MD | |
View Slides in PDF | |
11:11 AM - 11:16 AM | DEBATE: Early CEA In Symptomatic Carotid Stenosis Patients Within <2 Weeks Of The First Symptom Carries No Increased Risk Even If The Patient Is On Dual Antiplatelet Agents |
Presenter(s):Ross Naylor, MD, FRCS | |
View Slides in PDF | |
11:17 AM - 11:22 AM | DEBATE: Not So: Early CEA After Symptom Onset Has A Higher Risk Of Adverse Events (Death/Stroke) Than Delayed Operation: How Long Should CEA Be Delayed |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Current Optimal Ways To Manage Infected Carotid Patches When There Is No False Aneurysm And When There Is One |
Presenter(s):Ali F. AbuRahma, MD / Patrick A. Stone, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | DEBATE: CMS Data Based Studies Tell Us Correctly About CEA And CAS Results In Real World Practice |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | DEBATE: Not So: CMS Data Based Studies Are Flawed Models Sinking In The Quicksand Of Pseudo-Data |
Presenter(s):Richard P. Cambria, MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Update On The Status Of ACST-2 Comparing CEA And CAS In ACS Patients: Devices Used, Medical Treatments: Is CEA/CAS Equipoise For ACS Being Supported |
Presenter(s):Alison Halliday, MS, FRCS | |
View Slides in PDF | |
11:47 AM - 11:55 AM | Panel Discussion |
11:55 AM - 12:00 PM | Associate Faculty Awards Presentation |
Presenter(s):Enrico Ascher, MD / Alan Dardik, MD, PhD | |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
MORE NEW DEVELOPMENTS IN CAROTID DISEASE, ONGOING TRIALS AND CONTROVERSIES
Moderators:Brajesh K. Lal, MD / Frank J. Veith, MD
|
|
x | |
1:00 PM - 1:05 PM | Predictors Of Stroke And Death After CAS: Post-Stent Ballooning Is Bad And Proper Use Of Beta Blockers Is Good: Data From The SVS VQI |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Guidelines For Management Of Carotid Stenosis Are Outdated, Inconsistent And Flawed: It Is Time For An Overhaul And Update |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
View Slides in PDF | |
1:12 PM - 1:17 PM | How Do The SVS Guidelines For Management Of Extracranial Carotid Disease Impact On Clinical Practice: Do They Need To Be Updated |
Presenter(s):Enrico Ascher, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | What Are The Ongoing Carotid Trials (CREST-2, SPACE-2, ACST-2, ACT-1, ECST-2) Telling Us And Going To Tell Us |
Presenter(s):Alison Halliday, MS, FRCS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Status Of The SPACE-2 Trial: Although Patient Enrollment Has Been Stopped, What Useful Information Will It Provide |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | What Is Happening With CREST-2: When Will We Have Answers |
Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Why CREST-2 May Be A Bad Deal For CAS |
Presenter(s):Mark H. Wholey, MD | |
1:42 PM - 1:47 PM | Double Filtration Embolic Brain Protection During CAS Improves Outcomes: A Novel PTA Balloon With An Integrated Filter Helps To Do This: The Paladin Balloon |
Presenter(s):Ravish Sachar, MD | |
View Slides in PDF | |
Moderator(s): Thomas G. Brott, MD / Mark H. Wholey, MD | |
1:48 PM - 1:53 PM | DEBATE: Which Carotid Stenosis Patients Are Candidates For CAS In 2015: An Interventionist’s View |
Presenter(s):Klaus D. Mathias, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | DEBATE: Which Carotid Stenosis Patients Are Appropriate Candidates For CAS In 2015: A Vascular Surgeon’s View |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Slides in PDF | |
2:00 PM - 2:05 PM | What Lesion Characteristics Are Higher Risk For CAS Than CEA: How Should They Influence The Choice Of Treatment In Symptomatic And Asymptomatic Patients: Data From CREST |
Presenter(s):Wesley S. Moore, MD | |
View Slides in PDF | |
2:06 PM - 2:11 PM | DEBATE: Screening For Asymptomatic Carotid Stenosis (ACS) Is Justified In Some Patients: Which Ones And For What Reason |
Presenter(s):Glenn Jacobowitz, MD | |
View Slides in PDF | |
2:12 PM - 2:17 PM | DEBATE: Screening For ACS Is |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | CEA, CAS And Best Medical Treatment (BMRx) Alone: Which Treatment For Which Patient |
Presenter(s):R. Clement Darling III, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Early Intervention After Symptom Onset Is Safe With CEA But Not With CAS |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
View Slides in PDF | |
2:30 PM - 2:36 PM | Panel Discussion |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
LATE BREAKING IMPORTANT INFORMATION, KEY UPDATES AND PEVAR
Moderators:Pedro P. Komlos, MD / Mark A. Adelman, MD
|
|
x | |
2:36 PM - 2:41 PM | Statins Are Safe, Cheap And Effective And Should Be Used More Widely: Late Breaking Long-Term Results Of The MRC/BHF HEART PROTECTION Study Of Statins vs. Placebo |
Presenter(s):Richard Bulbulia, MA, MD, FRCS | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Do ACE Inhibitors Slow AAA Growth: The AARDVARK Trial |
Presenter(s):Janet T. Powell, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | What’s New With Stem Cell Treatment For Unfixable CLI: What About For Myocardial Ischemia |
Presenter(s):Alan Dardik, MD, PhD | |
View Slides in PDF | |
2:54 PM - 2:59 PM | Active Smoking Increases The Risk Of Limb Loss After Infrainguinal Bypass For Intermittent Claudication |
Presenter(s):Raghuveer Vallabhaneni, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Dual Antiplatelet Drugs Are Better Than One Drug For All Lower Extremity Arterial Interventions – Endo And Open |
Presenter(s):Marc L. Schermerhorn, MD | |
View Slides in PDF | |
UPDATE ON PEVAR | |
3:06 PM - 3:11 PM | Update On The Status Of Percutaneous EVAR And TEVAR: What Device Is Best, Who Should Not Have It, Precautions And What Improved Devices Are On The Horizon |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
View Slides in PDF | |
3:12 PM - 3:17 PM | Benefits Of PEVAR In More Than 3000 EVAR Cases: Technical Tips And How Can Costs Be Minimized |
Presenter(s):Giovanni Pratesi, MD / Bruno Freitas, MD / Dierk Scheinert, MD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Real World Results With PEVAR vs. Open Femoral Approaches For EVAR: They Are Not What Might Be Expected |
Presenter(s):Dipankar Mukherjee, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | Do Closure Devices Accelerate Femoral Artery Atherosclerosis |
Presenter(s):Luis R. Leon, MD, RVT, FACS | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Update On Facial Suture Technique For Minimally Invasive Sheath Insertion: Is It Better Than PEVAR: Tips And Tricks For Doing It Right |
Presenter(s):Thomas Larzon, MD, PhD | |
View Slides in PDF | |
3:36 PM - 3:41 PM | Endovascular AV Fistula Creation For Hemodialysis Access: Technique And Early Trial (NEAT) Results |
Presenter(s):Charmaine Lok, MD | |
View Slides in PDF | |
3:42 PM - 3:55 PM | Panel Discussion And Break Visits Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
NEW CONCEPTS AND UPDATES RELATED TO CAROTID DISEASE AND ITS TREATMENT
Moderators:Gregory L. Moneta, MD / Klaus D. Mathias, MD
|
|
x | |
3:55 PM - 4:00 PM | Current Optimal Management Of Infected Carotid Patches Without And With Pseudoaneurysms |
Presenter(s):Joseph S. Giglia, MD | |
View Slides in PDF | |
4:01 PM - 4:06 PM | Radial Or Brachial Access As A Primary Choice For CAS With A Bovine Arch: Technical Tips |
Presenter(s):Luigi Inglese, MD | |
View Slides in PDF | |
4:07 PM - 4:12 PM | Screening For ACS Is Important: Not To Increase Invasive Treatments But To Lead To Better Medical Treatment: Which Patients Should Be Screened |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Slides in PDF | |
4:13 PM - 4:18 PM | Cranial Nerve Injuries With CEA: What Are The Risk Factors: How Serious Are They: What Can Be Done To Prevent Them |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
4:19 PM - 4:24 PM | FDA Regulation Of CAS Devices: What Is Happening And What Does The Future Hold |
Presenter(s):Thomas G. Brott, MD | |
View Slides in PDF | |
4:25 PM - 4:30 PM | Carotid Artery Replacement With Resection Of Recurrent Neck Cancer: When Yes And When No Based On A RCT: Tips And Tricks |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
View Slides in PDF | |
4:31 PM - 4:36 PM | Is There A Current Role For EC-IC Bypasses Despite The Negative Level 1 Evidence: What Is Its This Role |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
4:37 PM - 4:42 PM | Will Transcarotid Approaches For CAS Be A Game Changer Even Without Any Specialized Devices And Why |
Presenter(s):Patrice F. Bergeron, MD | |
View Slides in PDF | |
4:43 PM - 4:49 PM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
NEW CONCEPTS AND UPDATES IN AORTIC DISEASE AND ITS TREATMENT
Moderators:Evan C. Lipsitz, MD / Benjamin W. Starnes, MD
|
|
x | |
4:49 PM - 4:54 PM | Recognition And Surgical Management Of Non-Aortic Pediatric Arterial Aneurysms |
Presenter(s):James C. Stanley, MD / Frank M. Davis, MD / Dawn M. Coleman, MD / Jonathan L. Eliason, MD | |
View Slides in PDF | |
4:55 PM - 5:00 PM | Comparative Performance Of FEVAR, Open Repair And Off-Label EVAR For Juxtarenal AAAs Not Suitable For Standard On-Label EVAR: Beyond A Single Center Experience |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS | |
View Slides in PDF | |
5:01 PM - 5:06 PM | Chimney EVAR For Juxtarenal AAAs Has A Less Deleterious Effect On Renal Function Than Open Repair |
Presenter(s):Zoran Rancic, MD, PhD | |
5:07 PM - 5:12 PM | When Do Parallel Grafts Work And When Don’t They And Why |
Presenter(s):William D. Jordan, Jr., MD | |
View Slides in PDF | |
5:13 PM - 5:18 PM | Surgical Infrarenal Aortic Graft Replacement As An Adjunct To Other Procedures: It Can Be A Useful Part Of A Hybrid Approach To Complex Aortic Pathology |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Slides in PDF | |
5:19 PM - 5:24 PM | Status Of The LEOPARD Trial To Compare Outcomes Of On-The-Bifurcation Fixation With The Endologix AFX EVAR Device To Current Proximally-Fixed EVAR Endografts |
Presenter(s):Christopher J. Kwolek, MD / Benjamin W. Starnes, MD | |
View Slides in PDF | |
5:25 PM - 5:30 PM | Why Is The Right Axillary Approach The Best For Inserting Chimney Grafts: Tips And Tricks For Inserting Multiple Chimneys Safely |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | DEBATE: Severely Angled Aortic Necks May Remodel Beneficially After EVAR, Minimizing The Need For Open Repair |
Presenter(s):Boonprasit Kritpracha, MD | |
View Slides in PDF | |
5:37 PM - 5:42 PM | DEBATE: No They Do Not: Minilap Open Repair Is Usually A Better Choice Than Off-Label Use Of EVAR Devices For AAAs |
Presenter(s):Francesco Spinelli, MD | |
View Slides in PDF | |
5:43 PM - 5:48 PM | For Aortic Operations On Scarred Or Heavily Calcified Aortas An Anastomotic Technique Using An Endograft Connector Avoids The Need For Difficult Aortic Dissection, Clamping And Suturing: The VORTEC Technique |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
5:49 PM - 5:55 PM | Panel Discussion End of Program K |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
NEW DEVELOPMENTS IN DISEASES OF THE POPLITEAL ARTERY; ANEURYSMS, OCCLUSIONS AND ENTRAPMENT
Moderators:Cynthia K. Shortell, MD / Ali F. AbuRahma, MD
|
|
x | |
POPLITEAL ANEURYSM RELATED TOPICS (SEE ALSO SESSION 28) | |
6:45 AM - 6:50 AM | Is Totally Endovascular Treatment A Good Option For Ruptured Popliteal Artery Aneurysms: Tips And Tricks |
Presenter(s):Francesco Setacci, MD | |
View Slides in PDF | |
6:51 AM - 6:56 AM | Is Totally Endovascular Treatment A Good Option For A Thrombosed Popliteal Aneurysm: Tips On How To Do It |
Presenter(s):Giovanni Pratesi, MD | |
View Slides in PDF | |
6:57 AM - 7:02 AM | Open Repair Of Asymptomatic Popliteal Aneurysm Is Associated With Better Outcomes Than Endo Repair: When Should Endo Repair Be Used |
Presenter(s):Mohammad H. Eslami, MD, RVT | |
View Slides in PDF | |
7:03 AM - 7:08 AM | DEBATE: What Have I Learned About Repairing Popliteal Aneurysms Since Peter Gloviczki And I Treated A Famous Popliteal Aneurysm Patient Almost 10 Years Ago |
Presenter(s):Barry T. Katzen, MD | |
View Slides in PDF | |
7:09 AM - 7:14 AM | DEBATE: What Have I Learned About Popliteal Aneurysms Since Barry Katzen And I Treated A Famous Popliteal Aneurysm Patient Almost 10 Years Ago |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
POPLITEAL OCCLUSIVE DISEASE | |
7:15 AM - 7:20 AM | What Is The Best Treatment For Treating Popliteal Occlusive Disease: PTA With Plain Balloons Or DEBs, When Stenting (Bare Or DES), When Atherectomy Or When Bypass |
Presenter(s):Jörn O. Balzer, MD, PhD | |
View Slides in PDF | |
7:21 AM - 7:26 AM | Effectiveness Of Zilver PTX DESs Placed Across The Knee Joint For Occlusive Disease: Long-Term Results |
Presenter(s):Marcelo Ferreira, MD | |
View Slides in PDF | |
POPLITEAL ENTRAPMENT SYNDROMES | |
7:27 AM - 7:32 AM | Popliteal Entrapment Syndromes: Optimizing Diagnosis And Treatment In 2015 And Beyond |
Presenter(s):Niten Singh, MD | |
View Slides in PDF | |
7:33 AM - 7:38 AM | Functional Popliteal Entrapment In High Performance Athletes: How To Diagnose It And How To Treat It By Partial Medial Gastrocnemius Resection: Why Does It Work |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
7:39 AM - 7:45 AM | Panel Discussion |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
NEW DEVELOPMENTS IN THE MANAGEMENT OF INFECTED ARTERIAL GRAFTS, EVARs, TEVARs AND MYCOTIC AAAs; USE OF ENDOGRAFTS TO TREAT AORTIC INFECTION AND AORTO-ENTERIC FISTULAS
Moderators:R. James Valentine, MD / Timur P. Sarac, MD
|
|
x | |
TREATMENT OF INFECTED EVARS AND TEVARS | |
7:45 AM - 7:50 AM | Surgical Treatment Of Infected Abdominal Endografts (EVARs): Techniques And Results From A Multicenter Study |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
7:51 AM - 7:56 AM | DEBATE: Management Of Infectious Complications Of EVARs And Aortic Graft Infections: The Graft Must Come Out |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
7:57 AM - 8:02 AM | DEBATE: Not So: New Concepts For Treating Infected EVARs And Aortic Grafts Less Invasively Can Work: Leaving The Graft In Place But Treating The Infected AAA Sac With Drainage/Irrigation Or Excision Can Be Effective And Less Morbid |
Presenter(s):Martin Malina, MD, PhD | |
View Slides in PDF | |
8:03 AM - 8:08 AM | How To Treat Infected FEVARs And TEVARs: What Strategies Work |
Presenter(s):Piotr M. Kasprzak, MD | |
View Slides in PDF | |
8:09 AM - 8:14 AM | Treatment Strategies For Infected Thoracic Endografts: The Graft Must Come Out: What If It Can’t |
Presenter(s):Christos D. Liapis, MD | |
View Slides in PDF | |
TREATMENT OF MYCOTIC AAAS WITH EVAR | |
8:15 AM - 8:20 AM | EVAR Is Durable Treatment For Mycotic AAAs – Sometimes: Other Adjuncts And Surveillance Are Vital: Results Of European Multicenter Study |
Presenter(s):Anders Wanhainen, MD, PhD | |
View Slides in PDF | |
8:21 AM - 8:26 AM | With Infected AAAs, EVAR Should Be The First Choice Treatment: Based On Over 80 Patients – Some Followed Over 10 Years: What Problems Can Arise And How Can They Be Managed |
Presenter(s):Boonprasit Kritpracha, MD | |
View Slides in PDF | |
8:27 AM - 8:33 AM | Panel Discussion |
MANAGEMENT OF AORTO-ENTERIC FISTULAS | |
Moderator(s): Thomas C. Bower, MD / Samuel R. Money, MD, MBA | |
8:33 AM - 8:38 AM | EVAR And TEVAR Can Be Definitive Treatment For Aorto-Enteric Fistulas: What Is Required |
Presenter(s):Furuzan Numan, MD | |
View Slides in PDF | |
8:39 AM - 8:44 AM | Successful Radical And Semi-Radical Treatment Of Aortobronchial And Aortoesophageal Fistulas After TEVAR: What Is Required For Survival – Which Is Possible |
Presenter(s):Ludovic Canaud, MD, PhD | |
View Slides in PDF | |
MORE ON INFECTED GRAFTS AND MYCOTIC AAAS | |
8:45 AM - 8:50 AM | New Developments In The Treatment Of Infected Aortic Grafts And Mycotic AAAs: What Strategies Work |
Presenter(s):Kamphol Laohapensang, MD | |
View Slides in PDF | |
8:51 AM - 8:56 AM | New Developments In The Treatment Of Aortic Graft Infection: How Do Silver Impregnated Grafts And Negative Wound Pressure Help To Preserve Infected Grafts And When Won’t These Measures Work |
Presenter(s):Max Zegelman, MD | |
View Slides in PDF | |
8:57 AM - 9:02 AM | Tips And Tricks To Deal With Infected Groin Wounds Containing Infected Grafts |
Presenter(s):Joseph S. Giglia, MD | |
View Slides in PDF | |
9:03 AM - 9:08 AM | How To Recognize Complications Of Femoral Vein Grafts Used To Treat Aortic Graft Infections And How To Manage These Complications |
Presenter(s):R. James Valentine, MD | |
View Slides in PDF | |
9:09 AM - 9:16 AM | Panel Discussion |
9:17 AM - 9:37 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
NEW DEVELOPMENTS IN HYBRID OPERATING SUITES AND IMPROVEMENTS IN IMAGING
Moderators:Daniel G. Clair, MD / Frans L. Moll, MD, PhD
|
|
x | |
9:37 AM - 9:42 AM | Advantages Of Fusion And How It Reduces Contrast And X-ray Dosage For Complex AAA Repairs: How To Eliminate Registration Errors Due To Changes In Anatomy From Vascular Devices, Sheaths And Wires |
Presenter(s):Neal S. Cayne, MD | |
View Slides in PDF | |
9:43 AM - 9:48 AM | Advances In Fusion Techniques To Make Them More Accurate: Use Of Vascular Calcium To Correct For Aortic Distortion From Sheaths And Wires And Automatic Fusion Registration And Re-Registration |
Presenter(s):Alan B. Lumsden, MD, FACS | |
9:49 AM - 9:54 AM | A New System For Automated 3D Fusion Overlay Which Works With All Digital Fluoroscopes – Fixed And MOBILE From All Manufacturers And Which Re-Registers With Patient And Table Movement |
Presenter(s):Tom Carrell, MD, MChir | |
View Slides in PDF | |
9:55 AM - 10:00 AM | A Modern Hybrid Room Will Reduce Radiation Dose And Protect Patients' Kidneys: Tips And Tricks To Use Such Rooms Optimally |
Presenter(s):Lieven F. Maene, MD | |
View Slides in PDF | |
10:01 AM - 10:06 AM | Rotation Angio-CT: What Is It And How Can It Improve Complex Endovascular Treatments Compared To Standard DSA And Pressure Measurements |
Presenter(s):Timothy A. Resch, MD, PhD | |
View Slides in PDF | |
10:07 AM - 10:12 AM | Update On New Assets In Hybrid Suites And How They Help Get Better Results |
Presenter(s):Stephan Haulon, MD | |
View Slides in PDF | |
10:13 AM - 10:18 AM | How To Train Hybrid Suite Staff Optimally For Complex Aortic Procedures: It’s Essential They Know About All Equipment |
Presenter(s):Rodney A. White, MD | |
View Slides in PDF | |
10:19 AM - 10:27 AM | Panel Discussion |
Moderator(s): Rodney A. White, MD / Alan B. Lumsden, MD, FACS | |
10:27 AM - 10:32 AM | Mobile C-Arm (Ziehm Vision RFT Hybrid) And Stille Mobile Floating Table Has Many Of The Advantages Of A Hybrid Room At A Lower Cost And They Can Function In Multiple ORs |
Presenter(s):Peter C.J. Goverde, MD | |
View Slides in PDF | |
10:33 AM - 10:38 AM | Intra-arterial Arteriography Does Not Always Accurately Reflect The Anatomy: What Can Be Done To Fix This Problem |
Presenter(s):Nicolas A. Diehm, MD | |
View Slides in PDF | |
10:39 AM - 10:44 AM | Can Optical Techniques Replace X-ray For Interventional Guidance: Some Specifics |
Presenter(s):Frans L. Moll, MD, PhD | |
View Slides in PDF | |
10:45 AM - 10:50 AM | Value Of Optical Coherence Tomography (OCT) In The Treatment Of Lower Extremity And Other Arteries: How Does It Work And What Are The Limitations |
Presenter(s):Vikram S. Kashyap, MD | |
View Slides in PDF | |
10:51 AM - 10:56 AM | Value Of IVUS To Evaluate Residual Stenoses After SFA Interventions And SPY To Evaluate Foot Tissue Perfusion To Assess Procedure Effectiveness: How Do They Work |
Presenter(s):Wei Zhou, MD | |
View Slides in PDF | |
10:57 AM - 11:11 AM | Panel Discussion |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME (TOS)
Moderators:Karl A. Illig, MD / Robert W. Thompson, MD
|
|
x | |
11:11 AM - 11:16 AM | What’s New In The Treatment Of TOS |
Presenter(s):Robert W. Thompson, MD | |
View Slides in PDF | |
11:17 AM - 11:22 AM | New SVS Reporting Standards For TOS: Highlights And What Is New And Different |
Presenter(s):Karl A. Illig, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Value Of Supraclavicular Approach To TOS And First Rib Resection: Technical Tips And Tricks To Simplify The Approach |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
11:29 AM - 11:34 AM | Robot Assisted Thoroscopic First Rib Resection Is The Approach Of Choice For TOS: Why And What Equipment And Skills Are Required |
Presenter(s):Hans M.E. Coveliers, MD, MBA | |
View Slides in PDF | |
11:35 AM - 11:40 AM | Treatment Of TOS In Competitive Athletes: When Is Surgical Treatment Indicated: Technical Tips And Tricks |
Presenter(s):Jason T. Lee, MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | How Can Cervical Ribs Cause A Stroke: What Is The Best Treatment If They Do |
Presenter(s):Fred A. Weaver, MD | |
View Slides in PDF | |
11:47 AM - 11:52 AM | Outpatient Surgery For TOS Is Safe And Effective: Technical Details, Precautions, And Requirements |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
11:53 AM - 0:00 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
NEW OR UPDATED CONCEPTS REGARDING VASCULAR TRAUMA, TAKAYASU’S DISEASE; AND MEDICAL TOPICS
Moderators:Richard J. Powell, MD / Vivian Gahtan, MD
|
|
x | |
1:00 PM - 1:05 PM | Improving Outcomes Of Treatment For Major Trauma (Vascular And Other) With Aortic Balloon Control And Other Over The Wire Endovascular Techniques: The REBOA Registry And How Aortic Balloon Control Should Work |
Presenter(s):Tal M. Hörer, MD, PhD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA) With A Low Profile Not Over-A-Guide Wire: How Does It Work And Value In Military And Civilian Injuries |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Update On A Simplified Aortic Occlusion Balloon System For RAAAs, Major Vascular Or Other Hemorrhagic Trauma: Does It Require Fluoro And Who Can Use It |
Presenter(s):Benjamin W. Starnes, MD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | What Is The Role Of Endovascular Treatments In Takayasu’s Disease Of The Aorta And Its Branches |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Pitfalls In The Endovascular Treatment Of Takayasu’s Disease: Should They Ever Be Used And When |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | DEBATE: Endovascular Treatments Should Be Used In Many Patients With Intermittent Claudication |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
1:36 PM - 1:41 PM | DEBATE: Not So: Exercise And Medical Therapy Are The Best Treatment For Almost All Patients With Intermittent Claudication |
Presenter(s):Erich Minar, MD | |
View Slides in PDF | |
1:42 PM - 1:47 PM | How To Predict Groin Wound Infections After Open Vascular Surgery: What Can Be Done To Prevent Them |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
1:48 PM - 1:53 PM | DEBATE: Statins Are Disruptive Safe Miracle Drugs And Should Be Used More Widely: Which Drug, What Dose And For Whom |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
1:54 PM - 1:59 PM | DEBATE: Not So: Statin Benefits Are Overblown And They Are Dangerous: They Should Be Used Less |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
View Slides in PDF | |
2:00 PM - 2:06 PM | Panel Discussion |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
PROGRESS AND UPDATES ON MEDICAL TREATMENTS AND OTHER SUBJECTS
Moderators:Elliot L. Chaikof, MD, PhD / Andrew N. Nicolaides, MS, FRCS
|
|
x | |
MEDICAL TREATMENTS | |
2:06 PM - 2:11 PM | How To Incorporate A Dedicated Cardiovascular Disease Prevention Program Into A Vascular Practice And Make It Work |
Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
View Slides in PDF | |
2:12 PM - 2:17 PM | Value Of Cilostazol (Pletal) In Vascular Patients: It’s Not Just For Claudication: Beneficial Effects, Who Should Get And At What Dose |
Presenter(s):Richard J. Powell, MD | |
View Slides in PDF | |
2:18 PM - 2:23 PM | With Vascular Patients And Vascular Procedures, When Are Beta Blockers Helpful: In What Dose And With What Precautions |
Presenter(s):Mark L. Friedell, MD | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Preoperative Beta Blockers Reduce Operative Mortality (30-Day) And Non-Cardiac Morbidity After Elective Open AAA Repair |
Presenter(s):Mahmoud B. Malas, MD, MHS | |
View Slides in PDF | |
2:30 PM - 2:35 PM | What Is New In Best Medical Therapy For Vascular Patients: How Can Its Effectiveness Be Measured: What LDL Level Should We Strive For; Can The LDL Level Ever Be Too Low |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
View Slides in PDF | |
2:36 PM - 2:41 PM | When And Why Should Vascular Surgeons Prescribe Maximal Dose Statins: What Dose Is This And What Are The Risks |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
2:42 PM - 2:47 PM | High Dose Ruvostatin (Crestor) Leads To Decreased Renal Damage After Contrast Arteriography: Should It Be Used More Widely As A Renal Protective Agent |
Presenter(s):Olivier H.J. Koning, MD, PhD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | When After Coronary Stenting With A DES Or BMS Is It Safe To Stop Clopidogrel And Perform An Open Operation: The Latest Update |
Presenter(s):Don Poldermans, MD | |
View Slides in PDF | |
2:54 PM - 3:02 PM | Panel Discussion |
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Russell H. Samson, MD, RVT, FACS | |
3:02 PM - 3:07 PM | Mortality Is A More Important End Point Than Stroke In Patients With An Asymptomatic Carotid Stenosis: What Can Be Done About It |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Slides in PDF | |
3:08 PM - 3:13 PM | Postoperative And Post-Procedural Myocardial Infarctions (MIs): Evaluation, Risk Factors And Optimal Prevention And Treatment: We Can Do More |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
CCSVI (SEE ALSO SESSION 97) | |
3:14 PM - 3:19 PM | Update On CCSVI And Interventions For MS: Role Of Autonomic Nervous System And Is There Still A Role For Angioplasty Of Vein Stenoses |
Presenter(s):Donald B. Reid, MD | |
3:20 PM - 3:25 PM | How Are 3D Navigational Tools Helpful In Lower Extremity Interventions |
Presenter(s):Jos C. van den Berg, MD, PhD | |
View Slides in PDF | |
3:26 PM - 3:31 PM | When Is Duplex Ultrasound Surveillance A Safe Alternative For CT Or MR – After EVAR; After Lower Extremity Revascularizations: What Are The Requirements |
Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD | |
View Slides in PDF | |
3:32 PM - 3:39 PM | Panel Discussion |
3:40 PM - 4:00 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
RECORDED LIVE CASES ON COMPLEX AAA AND TAAA REPAIRS WITH FENESTRATED AND BRANCHED ENDOGRAFTS
|
|
x | |
4:00 PM - 4:20 PM | Complex Cases From Mϋnster |
Presenter(s):Martin J. Austermann, MD / Giovanni Torsello, MD | |
View Slides in PDF | |
4:20 PM - 4:27 PM | Questions And Discussion |
4:28 PM - 4:48 PM | Complex Cases From The Mayo Clinic |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
View Slides in PDF | |
4:48 PM - 4:55 PM | Questions And Discussion |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
NEW CONCEPTS AND TECHNIQUES AND RADIATION SAFETY
Moderators:Lindsay Machan, MD / Barry T. Katzen, MD
|
|
x | |
4:55 PM - 5:00 PM | New Dose Aware System For Monitoring Staff Radiation Exposure As It Occurs |
Presenter(s):Mario L. Lachat, MD | |
View Slides in PDF | |
5:01 PM - 5:06 PM | Innovative Approach To Angiogenic Cell Therapy For CLI: Hope For The Future And BOLD MRI: A New Method To Measure Calf Perfusion To Monitor Its Effects |
Presenter(s):Bijan Modarai, PhD, FRCS | |
View Slides in PDF | |
5:07 PM - 5:12 PM | Duplex Imaging Is The Best Surveillance Method After EVAR With Chimney Grafts |
Presenter(s):Ross Milner, MD | |
View Slides in PDF | |
RADIATION SAFETY | |
5:13 PM - 5:18 PM | Radiation Protection Training And Coaching In A Simulated Hybrid Suite Markedly Reduces Radiation Exposure To Patients And Staff |
Presenter(s):Lars B. Lonn, MD, PhD | |
View Slides in PDF | |
5:19 PM - 5:24 PM | New Developments In Radiation Safety: Proper C-Arm Angulation, Dynamic Computer Assisted Collimation (Ikomed Technologies), Radiation Reducing Cap (No Brainer) And Avoiding Mag Views |
Presenter(s):Lindsay Machan, MD | |
View Slides in PDF | |
5:25 PM - 5:30 PM | Disposable Radiation Absorbing Surgical Drapes Reduces X-ray Exposure To Operators And Nurses |
Presenter(s):Marc R.H.M. van Sambeek, MD, PhD | |
View Slides in PDF | |
5:31 PM - 5:36 PM | Fixed vs. Mobile Imaging For Endovascular Procedures: Comparative Radiation Exposure To Staff Members: How Should Staff Dosage Best Be Quantitated |
Presenter(s):Vikram S. Kashyap, MD | |
View Slides in PDF | |
5:37 PM - 5:42 PM | Surgeon Or Operator Radiation Dose During Simple And Complex Endovascular Interventions: How Many Procedures Can An Operator Do Safely And How Can Dosage Be Decreased |
Presenter(s):Carlos H. Timaran, MD | |
View Slides in PDF | |
5:43 PM - 5:48 PM | How To Reduce Radiation Exposure With Endovascular Procedures |
Presenter(s):Barry T. Katzen, MD | |
View Slides in PDF | |
5:49 PM - 5:56 PM | Panel Discussion End of Program L |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
VENOUS CROSS-SECTIONAL IMAGING TECHNIQUES, PELVIC VENOUS INCOMPETENCE
|
|
x | |
7:00 AM - 7:05 AM | Introduction |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
7:06 AM - 7:11 AM | The Use Of IVUS To Document May-Thurner Anatomy |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
7:12 AM - 7:17 AM | How To Measure Iliac Vein Stenosis |
Presenter(s):Seshadri Raju, MD | |
View Slides in PDF | |
7:18 AM - 7:23 AM | Compare IVUS And Multi-Planar Venography For Proper Characterization Of The Occlusive Disease In The Iliac Veins And CFV |
Presenter(s):Paul J. Gagne, MD, FSIR, FACR | |
View Slides in PDF | |
7:24 AM - 7:29 AM | Novel Imaging Techniques With MRI For Thrombus Aging |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
7:30 AM - 7:35 AM | MRV And CTV In Imaging Of Pelvic And Abdominal Venous Compressive Syndromes: Which Is Better And Why |
Presenter(s):Constantino Pena, MD / Barry Stein, MD, FSIR, FACR | |
View Slides in PDF | |
7:36 AM - 7:41 AM | Image Fusion With MRV For 3D Guidance Of Deep Venous Interventions |
Presenter(s):Rick De Graaf, MD, PhD | |
View Slides in PDF | |
7:42 AM - 7:47 AM | Cone Beam CT vs. IVUS In Iliac Venous Stenting |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
7:48 AM - 7:52 AM | Panel Discussion |
7:53 AM - 7:58 AM | Pelvic Venous Duplex: How To Find The Pathology |
Presenter(s):Jan M. Sloves, RVT | |
View Slides in PDF | |
7:59 AM - 8:04 AM | Anatomy Of Pelvic Pathology |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
8:05 AM - 8:10 AM | How To Treat Vulvar Veins Before Or After Pelvic Embolization |
Presenter(s):Barrie A. Price, Mr, MD, MS, FRCS | |
View Slides in PDF | |
8:11 AM - 8:16 AM | How To Treat Peroneal Varicosities With Pelvic Symptoms: Combined Approach |
Presenter(s):Melvin Rosenblatt, MD | |
View Slides in PDF | |
8:17 AM - 8:22 AM | Embolization Has A Major Role In The Treatment Of Varicocele And Pelvic Congestion Syndrome |
Presenter(s):Lindsay Machan, MD | |
View Slides in PDF | |
8:23 AM - 8:28 AM | The Safety Of Coil Embolization Of Pelvic Veins And Subsequent Pregnancy |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
View Slides in PDF | |
8:29 AM - 8:34 AM | Ovarian Vein, Hypogastric Vein Incompetence Or Compression Syndrome: Coil, Stent, Both, Neither |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
8:35 AM - 8:40 AM | Should You Worry About The Left Renal Vein When Occluding The Left Ovarian Vein |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
8:41 AM - 8:46 AM | Acute Or Chronic Ovarian Vein Thrombosis: What To Do |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
8:47 AM - 8:52 AM | Nutcracker Syndrome: Favorable Outcomes With Endovascular Intervention (Over Open Repair) |
Presenter(s):Thomas S. Maldonado, MD | |
View Slides in PDF | |
8:53 AM - 8:58 AM | Panel Discussion |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION, HOT IDEAS FOR RECANALIZING CHRONIC TOTAL OCCLUSIONS
|
|
x | |
8:59 AM - 9:04 AM | Quality Of Life Assessment After Iliac Vein Stenting For DVT From May-Thurner Syndrome |
Presenter(s):Todd Berland, MD | |
View Slides in PDF | |
9:05 AM - 9:10 AM | Classification Of Anatomic Involvement Of The Iliocaval Venous Outflow Tract And Its Relationship To Outcomes After Iliocaval Venous Stenting |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
9:11 AM - 9:16 AM | Should Venous Interventions Be Performed In Patients With Right Heart Failure |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
9:17 AM - 9:22 AM | Crossing Femoro-Iliocaval Chronic Total Occlusions: Graduated Support And Tinkering |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
9:23 AM - 9:28 AM | Occluded Iliac Venous Stents: How I Recanalize |
Presenter(s):Seshadri Raju, MD / Erin H. Murphy, MD | |
View Slides in PDF | |
9:29 AM - 9:34 AM | Cutting Balloon Angioplasty For Femoropopliteal Stenoses/Synechiae Causing Venous Post-Thrombotic Syndrome |
Presenter(s):Thomas O. McNamara, MD | |
View Slides in PDF | |
9:35 AM - 9:40 AM | Technical Considerations And Emerging Technology For Chronic Venous Occlusions |
Presenter(s):Brian G. DeRubertis, MD | |
View Slides in PDF | |
9:41 AM - 9:46 AM | Update On EKOS “ACCESS DVT” Trial For Post-Thrombotic Syndrome |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
9:47 AM - 9:52 AM | What To Do When Inflow To Groin Is Poor |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
9:53 AM - 9:58 AM | Selection Criteria For Venous Angioplasty To Treat Post-Thrombotic Syndrome |
Presenter(s):Thomas O. McNamara, MD | |
View Slides in PDF | |
9:59 AM - 10:04 AM | An Update On VIVO-EU – The Zilver Vena Venous Stent Study In Europe |
Presenter(s):Gerard J. O'Sullivan, MD | |
View Slides in PDF | |
10:05 AM - 10:10 AM | VIRTUS: An Evaluation Of The VICI Venous Stent System In Patients With Chronic Iliofemoral Venous Outflow Obstruction |
Presenter(s):Mikel Sadek, MD | |
View Slides in PDF | |
10:11 AM - 10:16 AM | The UK Iliac Vein Stent Experience |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
10:17 AM - 10:22 AM | When And How To Use Sharp Devices For Iliocaval Recanalization |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
10:23 AM - 10:28 AM | Stent Fenestration, Z-Stents, Or Use Of The Azygous For Difficult Iliocaval Outflow |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
10:29 AM - 10:34 AM | What Is The Ideal Venous Stent |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
View Slides in PDF | |
10:35 AM - 10:40 AM | Panel Discussion |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
|
|
x | |
10:41 AM - 10:46 AM | Surgical Reconstruction Of The Deep Veins |
Presenter(s):Stephen A. Black, MD | |
View Slides in PDF | |
10:47 AM - 10:52 AM | Chronic Deep Venous Occlusive Disease: What Is The True Extent Of The Problem; Do We Know; Optimal Anticoagulation After Deep Venous Stenting |
Presenter(s):Manj S. Gohel, MD, RCS, FEBVS | |
View Slides in PDF | |
10:53 AM - 10:58 AM | Causes Of Failure Of Iliac Vein Stenting And What To Do About Them |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
10:59 AM - 11:04 AM | New Techniques In The Evaluation Of Lymphedema: Defining The Pathophysiology |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
11:05 AM - 11:10 AM | Deep Venous Valve Treatment: When And Why |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Slides in PDF | |
11:11 AM - 11:16 AM | A Novel Solution For Deep Venous Reflux: Endovenous Neovalve |
Presenter(s):Fedor Lurie, MD, PhD | |
View Slides in PDF | |
WOUNDS AND NEW HORIZONS | |
11:17 AM - 11:22 AM | RCT Demonstrating The Efficacy And Benefits Of Sulodexide Treatment In Patients With Venous Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Slides in PDF | |
11:23 AM - 11:28 AM | Definition Of Venous Ulcer: Clinical Evaluation Wound Care, Compression, Surgical Treatment, Ancillary Measures And Primary Prevention |
Presenter(s):Marc A. Passman, MD | |
View Slides in PDF | |
11:29 AM - 11:34 AM | Important RCTs For Venous Wound Healing |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
11:35 AM - 11:40 AM | The Argument For Surgical Intervention In Patients With Venous Ulcer, Based On Healthcare Savings |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Slides in PDF | |
11:41 AM - 11:46 AM | Proteomics And Degradomics In Venous Leg Ulcers |
Presenter(s):Joseph D. Raffetto, MD | |
View Slides in PDF | |
11:47 AM - 11:52 AM | Not All Leg Ulcers Are Venous |
Presenter(s):Raghu Kolluri, MD | |
View Slides in PDF | |
11:53 AM - 11:59 AM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM, INCLUDING THE AXILLOSUBCLAVIAN SYSTEM
Moderators:Joann Lohr, MD / Gregory L. Moneta, MD
|
|
x | |
1:00 PM - 1:05 PM | Do The NOACs Have Anti-Inflammatory Effects |
Presenter(s):Dawn M. Coleman, MD | |
View Slides in PDF | |
1:06 PM - 1:11 PM | Update On Reversal Agents For The NOACs |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
1:12 PM - 1:17 PM | Economy Class Syndrome: Air Travel-Related DVT And PE |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Slides in PDF | |
1:18 PM - 1:23 PM | Isolated Soleal And Gastrocnemius Vein Thrombosis |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
1:24 PM - 1:29 PM | Neurological Presentation Of IVC Occlusion During Pregnancy With No Visible Changes Of Venous Hypertension |
Presenter(s):Joann Lohr, MD | |
View Slides in PDF | |
1:30 PM - 1:35 PM | Biomarkers Of Venous Thromboembolism |
Presenter(s):Thomas W. Wakefield, MD | |
View Slides in PDF | |
1:36 PM - 1:41 PM | Unusual Presentation/Complications Of Undiagnosed Thrombophilia |
Presenter(s):Joann Lohr, MD | |
View Slides in PDF | |
1:42 PM - 1:48 PM | Infection/Inflammation Associated With Acute DVT: From The Clinic To Bench |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
1:49 PM - 1:54 PM | Experimental Insights Into PTS |
Presenter(s):Peter Henke, MD | |
View Slides in PDF | |
VTE INTERVENTIONAL | |
1:55 PM - 2:00 PM | Endovascular Management Of Ilio-Femoral DVT With Percutaneous Thrombectomy And Thrombolysis; Indications, Techniques And Results |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
View Slides in PDF | |
2:01 PM - 2:06 PM | Pharmacomechanical Thrombolysis Of Large Volume (Extensive) DVT Using The Rapid Lysis Technique |
Presenter(s):Mark J. Garcia, MD | |
View Slides in PDF | |
2:07 PM - 2:12 PM | ATTRACT Study: A Multicenter Randomized Trial To Evaluate Pharmacomechanical Catheter-Directed Thrombolysis |
Presenter(s):Constantino Pena, MD | |
View Slides in PDF | |
2:13 PM - 2:18 PM | First In Human Analysis Of The Aspirex Rotational Thrombectomy Catheter For Iliofemoral DVT |
Presenter(s):Michael K.W. Lichtenberg, MD | |
View Slides in PDF | |
2:19 PM - 2:23 PM | D-Dimer And/Or Duplex Findings To Manage DVT |
Presenter(s):Timothy K. Liem, MD, MBA | |
View Slides in PDF | |
2:24 PM - 2:29 PM | Impact Of Caval Occlusion On The Outcomes Of Thrombolysis For Iliofemoral DVT |
Presenter(s):Rabih A. Chaer, MD | |
View Slides in PDF | |
2:30 PM - 2:35 PM | Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting |
Presenter(s):Enrique Criado, MD, FACS | |
View Slides in PDF | |
2:36 PM - 2:41 PM | Management Of Paget Schroetter Syndrome In Athletes |
Presenter(s):Handel R. Robinson, MD | |
View Slides in PDF | |
2:42 PM - 2:47 PM | Incidence Of Upper Extremity DVT After Central Venous Catheterization And What To Do |
Presenter(s):Gregory L. Moneta, MD | |
View Slides in PDF | |
2:48 PM - 2:53 PM | Panel Discussion |
END OF SESSION 96 | |
SESSION 97 SCHEDULE | |
Friday
SESSION 97:
ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
Moderators:Peter Gloviczki, MD / William J. Quinones-Baldrich, MD
|
|
x | |
MORE FEMORAL-ILIOCAVAL FLOW ISSUES | |
2:54 PM - 2:59 PM | IVC Agenesis: Is This A Real Entity |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:00 PM - 3:05 PM | Caval Tumors |
Presenter(s):William A. Marston, MD | |
View Slides in PDF | |
3:06 PM - 3:11 PM | Evolution Of Venous In-Stent Stenosis: Do Anti-Platelet Agents Help Mitigate |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
3:12 PM - 3:17 PM | QOL After Deep Venous Recanalization Procedures: Any Relation To Patency |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
View Slides in PDF | |
3:18 PM - 3:23 PM | Conduit Choices For In-Line Caval Reconstruction |
Presenter(s):Peter Gloviczki, MD | |
View Slides in PDF | |
3:24 PM - 3:29 PM | IVC Replacement For Malignancy: How To Do It And What Is The Best Graft |
Presenter(s):Thomas C. Bower, MD | |
View Slides in PDF | |
3:30 PM - 3:35 PM | Difficult Femoral And Iliocaval Endovascular Reconstructions: Lessons Learned |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
3:36 PM - 3:41 PM | Patient Selection For In-Line Caval Reconstruction |
Presenter(s):William J. Quinones-Baldrich, MD | |
View Slides in PDF | |
3:42 PM - 3:47 PM | Endovascular Treatment Of Superior Vena Cava Syndrome Because Of Central Vein Occlusion |
Presenter(s):Narendra N. Khanna, MD, DM, FRCP, FACC | |
View Slides in PDF | |
3:48 PM - 3:53 PM | Venous Atherectomy: Just Saying |
Presenter(s):Jose I. Almeida, MD, RVT, RPVI, FACS | |
View Slides in PDF | |
3:54 PM - 3:59 PM | Open Surgery For CCSVI Reduces The Brain Ventricles Volume |
Presenter(s):Paolo Zamboni, MD | |
View Slides in PDF | |
CAVAL FILTRATION ISSUES | |
4:00 PM - 4:05 PM | Indications For IVC Filters: Are They Being Observed |
Presenter(s):John E. Rectenwald, MD, MS | |
View Slides in PDF | |
4:06 PM - 4:11 PM | Update On The Sentry Bioconvertible Non-Retrieval IVC Filter |
Presenter(s):David Rosenthal, MD | |
View Slides in PDF | |
4:12 PM - 4:17 PM | Robotic Vena Cava Surgery |
Presenter(s):Samuel R. Money, MD, MBA | |
View Slides in PDF | |
4:18 PM - 4:23 PM | The PREPIC Trial: Fact Or Fiction |
Presenter(s):John E. Rectenwald, MD, MS | |
View Slides in PDF | |
4:24 PM - 4:29 PM | Update On The PRESERVE Vena Cava Filter Study |
Presenter(s):David L. Gillespie, MD | |
View Slides in PDF | |
4:30 PM - 4:35 PM | Early Clinical Experience With The Celect Platinum Filter, With Focused Pre-Retrieval Imaging Planning |
Presenter(s):Atul Gupta, MD | |
View Slides in PDF | |
4:36 PM - 4:41 PM | Major Complications After IVC Filter Placement And How To Avoid Them |
Presenter(s):Clifford M. Sales, MD, MBA, FACS | |
View Slides in PDF | |
4:42 PM - 4:47 PM | IVC Filter Retrieval Rates: The Influence Of Filter Design, Practice Administration And The Operator |
Presenter(s):Richard G. McWilliams, FRCR, EBIR | |
View Slides in PDF | |
4:48 PM - 4:53 PM | IVC Recanalization In The Presence Of A Thrombosed IVC Filter |
Presenter(s):David M. Williams, MD | |
View Slides in PDF | |
4:54 PM - 5:00 PM | Panel Discussion End of Program M |
END OF SESSION 97 | |
SESSION 98 SCHEDULE | |
Friday
SESSION 98:
CLASSIFICATION, IMAGING, AND PHARMCO-THERAPY
|
|
x | |
7:55 AM - 8:00 AM | Introduction |
Presenter(s):Krassi Ivancev, MD, PhD | |
8:00 AM - 8:10 AM | Current Classification And Nomenclature Of Vascular Malformations |
Presenter(s):Patricia E. Burrows, MD | |
View Slides in PDF | |
8:10 AM - 8:20 AM | The Hamburg Classification In Vascular Malformations: Clinical Applications Of The System |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
8:20 AM - 8:30 AM | 2015 ISSVA Classification Update |
Presenter(s):Francine Blei, MD, MBA | |
View Slides in PDF | |
8:30 AM - 8:40 AM | Vascular Tumors Confused With Vascular Malformations |
Presenter(s):Francine Blei, MD, MBA | |
View Slides in PDF | |
8:40 AM - 8:50 AM | New Imaging Modalities Essential For Accurate Diagnosis Of Vascular Malformations |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
8:50 AM - 9:00 AM | The Houdart CNS AVM Classification, The Do Peripheral AVM Classification, And The Yakes AVM Classification And Its Therapeutic Implications |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
9:00 AM - 9:10 AM | Update On the Role Of Pharmco-Therapy In Vascular Malformations |
Presenter(s):Gresham T. Richter, MD | |
9:10 AM - 9:20 AM | The Role Of Medical Therapies For Pediatric Hemangioma And Vascular Malformations |
Presenter(s):Francine Blei, MD, MBA | |
View Slides in PDF | |
9:20 AM - 9:40 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 98 | |
SESSION 99 SCHEDULE | |
Friday
SESSION 99:
HEAD AND NECK VASCULAR MALFORMATION TREATMENT ISSUES
|
|
x | |
9:40 AM - 9:50 AM | Dangerous Arterial Connections In The Head And Neck: Avoiding Vascular Neurological Complications And The Judicious Use Of Embolic Agents |
Presenter(s):Guilherme Dabus, MD | |
View Slides in PDF | |
9:50 AM - 10:00 AM | Endovascular Treatment Of Retinoblastoma: A Primary Form Of Therapy |
Presenter(s):Pierre Gobin, MD | |
View Slides in PDF | |
10:00 AM - 10:10 AM | Endovascular Treatment Of Dural AVF: A Complex Acquired Vascular Lesion With Microfistulae Involving The Dural Sinuses |
Presenter(s):Philip M. Meyers, MD | |
View Slides in PDF | |
10:10 AM - 10:20 AM | Liquid Embolic Agents In The Treatment Of Craniofacial AVMs And AVSs: Techniques And Results |
Presenter(s):Guilherme Dabus, MD | |
View Slides in PDF | |
10:20 AM - 10:30 AM | Management Of Complex Head And Neck Low-Flow Venous And Lymphatic Malformations |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
10:30 AM - 10:40 AM | AVMs: Staged Multimodal Therapy For the Most Aggressive Head And Neck Vascular Malformations |
Presenter(s):Gresham T. Richter, MD | |
10:40 AM - 10:50 AM | The Otolaryngologist’s Distinct Role In The Multidisciplinary Vascular Malformation Management Team |
Presenter(s):Edward J. Hepworth, MD | |
View Slides in PDF | |
10:50 AM - 11:00 AM | Current Surgical Indications For Infantile Hemangioma In The Era Of Propranolol |
Presenter(s):Gresham T. Richter, MD | |
11:00 AM - 11:10 AM | Surgical Reconstructive Techniques Post-Endovascular Ablation Of Head And Neck Vascular Malformation |
Presenter(s):Randolph C. Robinson, MD, DDS | |
View Slides in PDF | |
11:10 AM - 11:15 AM | Onyx AVM Embolotherapy: The Histologic Tissue Changes, Tissue Inflammatory Response, Fluoroscopy Issues, And Endovascular Issues With Its Use |
Presenter(s):Mollie Meek, MD | |
View Slides in PDF | |
11:15 AM - 11:25 AM | Laser Therapy For Cutaneous Vascular Anomalies |
Presenter(s):Gresham T. Richter, MD | |
11:25 AM - 11:35 AM | Curative Endovascular Treatment Of Complex Multiple AVMs Of The Head And Neck |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
11:35 AM - 12:55 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (3rd Floor) |
END OF SESSION 99 | |
SESSION 100 SCHEDULE | |
Friday
SESSION 100:
EXTREMITY LOW-FLOW VASCULAR MALFORMATION MANAGEMENT ISSUES
|
|
x | |
12:55 PM - 1:05 PM | Pitfalls In Superficial Vascular Malformation Endovascular Management |
Presenter(s):Emmanuel M. Houdart, MD | |
View Slides in PDF | |
1:05 PM - 1:15 PM | Management Of Vascular Anomalies In Genetic And Syndromic Disorders |
Presenter(s):Ahmad Alomari, MD, MSc, FSIR | |
View Slides in PDF | |
1:15 PM - 1:25 PM | Treatment Of Vascular Malformations In Infants |
Presenter(s):Patricia E. Burrows, MD | |
View Slides in PDF | |
1:25 PM - 1:35 PM | Special Diagnostic Considerations In Vascular Malformation Patients |
Presenter(s):Cynthia K. Shortell, MD | |
View Slides in PDF | |
1:35 PM - 1:45 PM | Treatment Of Intramuscular Venous Malformations Of The Extremities |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
1:45 PM - 1:55 PM | Ethanol Ablation Of Venous Malformations Of The Chest, Abdomen, And Buttocks |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
1:55 PM - 2:05 PM | Surgical Approaches To Vascular Malformation M anagement: Triumphs And Pitfalls |
Presenter(s):Christopher J. Morin, MD | |
View Slides in PDF | |
2:05 PM - 2:15 PM | Surgical Concepts To Treat The Lateral Marginal Vein Of The Lower Extremity |
Presenter(s):Byung-Boong Lee, MD | |
View Slides in PDF | |
2:15 PM - 2:25 PM | Imaging And Management Of Chylous Leak |
Presenter(s):Ahmad Alomari, MD, MSc, FSIR | |
View Slides in PDF | |
2:25 PM - 2:35 PM | Extensive Venous Malformations: How To Proceed With Low Platelets, Low Fibrinogen, And High D-Dimers |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
2:35 PM - 2:45 PM | Venous Malformations Of The Lower Extremity: Long-Term Follow-Up |
Presenter(s):Patricia E. Burrows, MD | |
View Slides in PDF | |
2:45 PM - 3:05 PM | Break – Visits Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 100 | |
SESSION 101 SCHEDULE | |
Friday
SESSION 101:
AV MANAGEMENT: CURRENT CONTROVERSIES IN VARIOUS TREATMENT STRATEGIES
|
|
x | |
3:05 PM - 3:15 PM | Common Femoral And Iliac Arterial Sparing Endovascular Techniques In Neonates |
Presenter(s):Patricia E. Burrows, MD | |
3:15 PM - 3:25 PM | Non-Traumatic Acquired AVMs: More Common Than We Realize |
Presenter(s):Robert L. Vogelzang, MD | |
3:25 PM - 3:35 PM | Fibro-Adipose Vascular Anomaly (FAVA) Of The Extremities: A Clinical-Radiological-Pathologic Review |
Presenter(s):Ahmad Alomari, MD, MSc, FSIR | |
3:35 PM - 3:45 PM | Curative Treatment Of Complex And Multiple Intraosseous AVMs |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
3:45 PM - 3:55 PM | Long-Term Outcomes For The Treatment Of Vascular Malformations: The Chicago Northwestern Experience |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
3:55 PM - 4:05 PM | Staged Endovascular Management Of Pelvic AVMs With nBCA |
Presenter(s):Robert J. Rosen, MD | |
View Slides in PDF | |
4:05 PM - 4:15 PM | Transvenous Endovascular And Percutaneous Treatment Of AVMs: Determining The Pathologic Aneurysmal Vein |
Presenter(s):Robert L. Vogelzang, MD | |
4:15 PM - 4:25 PM | Vascular Malformation Repair Procedures: An International Road Show – Lessons Learned |
Presenter(s):Krassi Ivancev, MD, PhD | |
4:25 PM - 4:35 PM | Endovascular Management Of Thoracic, Abdominal, And Mesenteric/Small Bowel AVMs |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
4:35 PM - 4:45 PM | Current Percutaneous Embolotherapy Techniques For Curative Treatment Of AVMs Of The Foot |
Presenter(s):Iris Baumgartner, MD | |
View Slides in PDF | |
4:45 PM - 4:55 PM | Intralipomatous Capillary-Venous Malformations: Endovascular And Surgical Considerations Of A Challenging New Entity |
Presenter(s):Christopher J. Morin, MD | |
View Slides in PDF | |
4:55 PM - 5:05 PM | Curative Endovascular Management Strategies For Yakes Types IIb, IIIa, And IIIb AVMs |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Slides in PDF | |
5:05 PM - 5:10 PM | The Yakes Type IV AVM (Characterized By Total Tissue AVM Infiltration Complicated By Capillaries Admixed Within The Innumerable AVFs): Angio-Architecture Features And Curative Endovascular Treatment Strategies To Preserve The Involved Tissue |
Presenter(s):Robert L. Vogelzang, MD | |
View Slides in PDF | |
5:10 PM - 5:15 PM | Closing Remarks |
Presenter(s):Robert L. Vogelzang, MD | |
5:15 PM - 5:15 PM | End of Program N |
END OF SESSION 101 |